New drug gives hope of slowing cognitive decline in Alzheimer’s patients
Lecanemab appeared to slow down cognitive and functional decline in Alzheimer’s patients in a clinical trial, but there were also adverse effects noted.
Read more: New drug gives hope of slowing cognitive decline in Alzheimer’s patients